healthy subjects

• A randomized, balanced, two-treatment, two-sequence, single oral dose, two stage crossover adaptative bioequivalence study of Rifaximin 200 … Pending
  2025-525078-12-00 2
• A Single Dose, Fast state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (IASIS PHARMA) vs.FU … Ended
  2024-517967-22-00 2 2025-02-25
• A Single Dose, Fasting state, Crossover Replicate Bioequivalence Study of Naproxen 500 mg/Esomeprazole 20 mg, modified-release tablets (Anti … Ended
  2024-515662-14-00 2 2024-10-31
• Safety Assessment of 10-Day Daily Bucco-Oral Administration of Transfer Factor in Healthy Adult Human Subjects Ended
  2024-511448-17-02 1 2024-10-16
• A Single Dose, Two – stage, Fasting State, Bioequivalence Study of Rifaximin 200 mg, film-coated tablets (Antibiotice S.A.) vs. Normix® 200 … Ended
  2024-510671-38-00 2 2024-05-26
• A Single Dose, Fed state, Crossover Replicate, Bioequivalence Study of Naproxen 500 mg/ Esomeprazole 20 mg modified-release tablets (Antibio … Ended
  2023-508621-27-00 2 2024-03-05
• Rivaroxaban sotorasib interaction study Ended
  2023-505557-41-00 6 2023-11-09
• A Single Dose, Fed state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (Iasis Pharma) vs. FU … Ended
  2023-503887-18-00 2 2023-10-02
• A Single Dose, Fast State, Bioequivalence Study of CEFIXIMA ATB 400 mg Hard Capsules (Antibiotice S.A.) vs. CEFIXORAL® 400 mg Film Coated Ta … Ended
  2023-504011-33-00 2 2023-06-12
• Tramadol Administered Orally to Healthy Subjects for the Improvement of its Detection in Biological Matrices in the Context of Anti-Doping … Ended
  2023-503799-25-00 3 2023-04-27

Showing 1–10 of 10 trials